BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 22920721)

  • 1. Deregulation of miR-100, miR-99a and miR-199b in tissues and plasma coexists with increased expression of mTOR kinase in endometrioid endometrial carcinoma.
    Torres A; Torres K; Pesci A; Ceccaroni M; Paszkowski T; Cassandrini P; Zamboni G; Maciejewski R
    BMC Cancer; 2012 Aug; 12():369. PubMed ID: 22920721
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of endometrioid endometrial carcinoma-associated microRNAs in tissue and plasma.
    Tsukamoto O; Miura K; Mishima H; Abe S; Kaneuchi M; Higashijima A; Miura S; Kinoshita A; Yoshiura K; Masuzaki H
    Gynecol Oncol; 2014 Mar; 132(3):715-21. PubMed ID: 24491411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic and prognostic significance of miRNA signatures in tissues and plasma of endometrioid endometrial carcinoma patients.
    Torres A; Torres K; Pesci A; Ceccaroni M; Paszkowski T; Cassandrini P; Zamboni G; Maciejewski R
    Int J Cancer; 2013 Apr; 132(7):1633-45. PubMed ID: 22987275
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Shikonin suppresses proliferation and induces apoptosis in endometrioid endometrial cancer cells via modulating
    Huang C; Hu G
    Biosci Rep; 2018 Apr; 38(2):. PubMed ID: 29449346
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integrated microRNA and mRNA transcriptome sequencing reveals the potential roles of miRNAs in stage I endometrioid endometrial carcinoma.
    Xiong H; Li Q; Liu S; Wang F; Xiong Z; Chen J; Chen H; Yang Y; Tan X; Luo Q; Peng J; Xiao G; Jiang Q
    PLoS One; 2014; 9(10):e110163. PubMed ID: 25329664
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miR-200a, miR-200b and miR-429 are onco-miRs that target the PTEN gene in endometrioid endometrial carcinoma.
    Yoneyama K; Ishibashi O; Kawase R; Kurose K; Takeshita T
    Anticancer Res; 2015 Mar; 35(3):1401-10. PubMed ID: 25750291
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discriminating miRNA Profiles between Endometrioid Well- and Poorly-Differentiated Tumours and Endometrioid and Serous Subtypes of Endometrial Cancers.
    Kalinkova L; Kajo K; Karhanek M; Wachsmannova L; Suran P; Zmetakova I; Fridrichova I
    Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32842533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-199a-3p regulates endometrial cancer cell proliferation by targeting mammalian target of rapamycin (mTOR).
    Wu D; Huang HJ; He CN; Wang KY
    Int J Gynecol Cancer; 2013 Sep; 23(7):1191-7. PubMed ID: 23851675
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-503 suppresses proliferation and cell-cycle progression of endometrioid endometrial cancer by negatively regulating cyclin D1.
    Xu YY; Wu HJ; Ma HD; Xu LP; Huo Y; Yin LR
    FEBS J; 2013 Aug; 280(16):3768-79. PubMed ID: 23731275
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MiRNAs in endometrioid endometrial cancer metastatic loci derived from positive lymph nodes.
    Wilczynski M; Senderowska D; Krawczyk T; Szymanska B; Malinowski A
    Acta Obstet Gynecol Scand; 2020 Aug; 99(8):1085-1091. PubMed ID: 32100871
    [TBL] [Abstract][Full Text] [Related]  

  • 11. UPF1 impacts on mTOR signaling pathway and autophagy in endometrioid endometrial carcinoma.
    Zhang M; Chen H; Qin P; Cai T; Li L; Chen R; Liu S; Chen H; Lin W; Chen H; Strickland AL; Xiong H; Jiang Q
    Aging (Albany NY); 2021 Sep; 13(17):21202-21215. PubMed ID: 34520393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disrupting MALAT1/miR-200c sponge decreases invasion and migration in endometrioid endometrial carcinoma.
    Li Q; Zhang C; Chen R; Xiong H; Qiu F; Liu S; Zhang M; Wang F; Wang Y; Zhou X; Xiao G; Wang X; Jiang Q
    Cancer Lett; 2016 Dec; 383(1):28-40. PubMed ID: 27693631
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Down-regulation of miR-145 and miR-143 might be associated with DNA methyltransferase 3B overexpression and worse prognosis in endometrioid carcinomas.
    Zhang X; Dong Y; Ti H; Zhao J; Wang Y; Li T; Zhang B
    Hum Pathol; 2013 Nov; 44(11):2571-80. PubMed ID: 24071015
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selection and validation of endogenous controls for microRNA expression studies in endometrioid endometrial cancer tissues.
    Torres A; Torres K; Wdowiak P; Paszkowski T; Maciejewski R
    Gynecol Oncol; 2013 Sep; 130(3):588-94. PubMed ID: 23811003
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [MicroRNA expression signature profile and its clinical significance in endometrioid carcinoma].
    Wang Y; Adila S; Zhang X; Dong Y; Li W; Zhou M; Li T
    Zhonghua Bing Li Xue Za Zhi; 2014 Feb; 43(2):88-94. PubMed ID: 24742567
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MiR-100-5p, miR-199a-3p and miR-199b-5p induce autophagic death of endometrial carcinoma cell through targeting mTOR.
    Cai J; Zhang Y; Huang S; Yan M; Li J; Jin T; Bao S
    Int J Clin Exp Pathol; 2017; 10(9):9262-9272. PubMed ID: 31966798
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HDAC6, modulated by miR-206, promotes endometrial cancer progression through the PTEN/AKT/mTOR pathway.
    Zheng Y; Yang X; Wang C; Zhang S; Wang Z; Li M; Wang Y; Wang X; Yang X
    Sci Rep; 2020 Feb; 10(1):3576. PubMed ID: 32107418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estrogen affects the negative feedback loop of PTENP1-miR200c to inhibit PTEN expression in the development of endometrioid endometrial carcinoma.
    Chen R; Zhang M; Liu W; Chen H; Cai T; Xiong H; Sheng X; Liu S; Peng J; Wang F; Chen H; Lin W; Xu X; Zheng W; Jiang Q
    Cell Death Dis; 2018 Dec; 10(1):4. PubMed ID: 30584245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The FOXO1-miR27 tandem regulates myometrial invasion in endometrioid endometrial adenocarcinoma.
    Mozos A; Catasús L; D'Angelo E; Serrano E; Espinosa I; Ferrer I; Pons C; Prat J
    Hum Pathol; 2014 May; 45(5):942-51. PubMed ID: 24746199
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MiR-99a inhibits cell proliferation of nasopharyngeal carcinoma by targeting mTOR and serves as a prognostic factor.
    Wu SH; Han L; Lu BC; Wang HY; Zheng CP
    Eur Rev Med Pharmacol Sci; 2019 Mar; 23(5):2053-2061. PubMed ID: 30915749
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.